Stock Events

Stock Events

GB Sciences 

$0
6
+$0+0% Friday 14:30

Statistics

Day High
0
Day Low
0
52W High
0.01
52W Low
0
Volume
31,000
Avg. Volume
132,398
Mkt Cap
122,121.3
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

9NovExpected
Q3 2020
Q4 2020
Q2 2021
Q3 2021
Q4 2021
Q2 2022
Q3 2022
-0
0
0.01
0.01
Expected EPS
N/A
Actual EPS
-0.0009

Financials

-Profit Margin
Unprofitable
2018
2019
2020
2021
2022
2023
0Revenue
-3.28MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow GBLX. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Cronos Group
CRON
Mkt Cap962.94M
Cronos Group is involved in the production and sale of cannabis and cannabis-derived products, making it a competitor in the cannabis market space.
Tilray Brands
TLRY
Mkt Cap1.5B
Tilray is a global leader in cannabis research, cultivation, processing, and distribution, competing with GB Sciences in the medicinal cannabis sector.
Canopy Growth
CGC
Mkt Cap418.51M
Canopy Growth Corporation is a diversified cannabis and cannabinoid-based consumer product company, competing across several of GB Sciences' target markets.
Aurora Cannabis
ACB
Mkt Cap280.01M
Aurora Cannabis is engaged in the production, distribution, and sale of cannabis products, directly competing with GB Sciences in the cannabis industry.
Organigram Global
OGI
Mkt Cap217.58M
OrganiGram Holdings is a producer of medical and recreational cannabis, competing with GB Sciences in both markets.
Curaleaf
CURLF
Mkt Cap2.16B
Curaleaf Holdings operates in the medical and recreational cannabis sectors, making it a direct competitor to GB Sciences in multiple aspects of the cannabis industry.

About

GB Sciences, Inc. engages in the research and development of plant-based medicines in North America and Europe. The company offers cannabinoid-inspired medicines and complex therapeutic mixtures for the prescription drug market. Its intellectual property covers a range of conditions and programs in pre-clinical animal stage for Parkinson's disease, neuropathic pain, chronic pain, COVID-related cytokine release syndrome, depression/anxiety, and cardiovascular therapeutic programs. The company was formerly known as Growblox Sciences, Inc. and changed its name to GB Sciences, Inc. in October 2016. GB Sciences, Inc. was incorporated in 2001 and is based in Las Vegas, Nevada.
Show more...
CEO
Dr. Andrea Small-Howard M.B.A., MBA, Ph.D.
Employees
2
Country
US
ISIN
US3615441090

Listings

OTC Link
US
GBLX

0 Comments

Share your thoughts

FAQ

What is GB Sciences stock price today?▼
The current price of GBLX is $0 USD — it has increased by +0% in the past 24 hours. Watch GB Sciences stock price performance more closely on the chart.
What is GB Sciences stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange GB Sciences stocks are traded under the ticker GBLX.
Is GB Sciences stock price growing?▼
GBLX stock has fallen by -40% compared to the previous week, the month change is a -40% fall, over the last year GB Sciences has showed a -92.86% decrease.
What is GB Sciences market cap?▼
Today GB Sciences has the market capitalization of 122,121.3
What were GB Sciences earnings last quarter?▼
GBLX earnings for the last quarter are -0 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is GB Sciences revenue for the last year?▼
GB Sciences revenue for the last year amounts to 0 USD.
What is GB Sciences net income for the last year?▼
GBLX net income for the last year is -3.28M USD.
How many employees does GB Sciences have?▼
As of February 09, 2026, the company has 2 employees.
In which sector is GB Sciences located?▼
GB Sciences operates in the Health Care sector.
When did GB Sciences complete a stock split?▼
The last stock split for GB Sciences was on October 31, 2013 with a ratio of 1:10.
Where is GB Sciences headquartered?▼
GB Sciences is headquartered in Las Vegas, US.